Simple Summary Circulating cell-free DNA (cfDNA) has attracted a great deal of scientific
interest as a predictive biomarker for the diagnosis and prognosis of hepatocellular …

The past several decades have witnessed unprecedented progress in basic and clinical
cancer research, and our understanding of the molecular mechanisms and pathogenesis of …

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and a
leading cause of cancer-related deaths. Due to late diagnosis, early intrahepatic metastasis …

As a kind of novel non-invasive marker for molecular detection, cell-free DNA (cfDNA) has
potential value for the early diagnosis of diseases, prognosis assessment, and efficacy …

Simple Summary Liquid biopsy for cell-free DNA (cfDNA) is a non-invasive technique to
characterize the genetic profile of a tumor. Despite being a valuable tool, there is no …

Hepatocellular carcinoma (HCC) is the sixth most common malignancy worldwide,
representing the third leading cause of cancer-related deaths. HCC genetic characterization …

Over the past decade, the advancements in massively parallel sequencing have provided a
new paradigm in biomedical research to uncover the genetic basis of human diseases …

Most hepatocellular carcinomas (HCCs) are associated with hepatitis B virus infection (HBV)
in China. Early detection of HCC can significantly improve prognosis but is not yet fully …

Background Plasma cell-free DNA (cfDNA) fragmentomics has demonstrated significant
differentiation power between cancer patients and healthy individuals, but little is known in …

Although circulating cell-free DNA (cfDNA) is a promising biomarker for the diagnosis and
prognosis of various tumors, clinical correlation of cfDNA with gastric cancer has not been …